1 / 6

Viral Vector and Plasmid DNA Manufacturing Market Forecast to 2027

A viral vector is a DNA molecule used as a vehicle to carry foreign genetic material into another cell, where it can be replicated. Vector is a plasmid manipulated artificially after ligation and digestion reaction series, whereas a plasmid naturally occurs in bacterial cells.

KiranGaikwad
Download Presentation

Viral Vector and Plasmid DNA Manufacturing Market Forecast to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Viral Vector and Plasmid DNA Manufacturing Market To Reach USD 2,493.80 Million By 2026

  2. Market Summary The rise in prevalence of cancer, inherited disorders, viral infections, Alzheimer’s, Parkinson’s, rheumatoid arthritis are the major growth factors for viral vector and plasmid DNA manufacturing market. Besides, the growing number of gene modified therapies like Yescarta and Kymriah are also fueling the market growth. According to the current analysis of Reports and Data, the global Viral Vector and Plasmid DNA manufacturing market is expected to reach USD 2,493.80 million by the year 2026, with a CAGR of 23.8% during the forecast period. Viral and non-viral vectors have emerged as an efficient delivery mechanism for the development of innovative medicines. Viral vectors and plasmid DNA are products of gene therapy, which are used for the treatment of a large number of diseases such as cancer and other chronic disorders.  Further key findings from the report suggest : By application, cancer is expected to account for the largest share of the market, followed by genetic disorder segment, which occupied a market share of around 33.3% in 2017. The viral vector and plasmid DNA manufacturing market in the Asia Pacific is projected to expand at a notable CAGR due to increasing awareness regarding viral vector-based products in developing countries and rising research initiatives in countries such as Japan and China. www.reportsanddata.com

  3. Key Players: • FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A, Fin vector, Spark therapeutics, Cobra biologics, Cell and gene therapy catapult, Renova Therapeutics, Shenzhen SiBionoGeneTech Co., Ltd, Thermo Fisher Scientific, Inc, 4D Molecular Therapeutics • Segmentation: • By Product (Revenue, USD Million; 2016-2026),Plasmid DNA, Viral Vectors, Non-viral Vectors • By Workflow (Revenue, USD Million, 2014 - 2026), Upstream Processing, Vector Amplification & Expansion, Vector Recovery/Harvesting, Downstream Processing, Purification, Fill-finish • By Disease (Revenue, USD Million; 2016-2026), Cancer, Inherited Disorders, Viral Infections, Others • By Application (Revenue, USD Million, 2016-2026), Antisense, RNAi, & Molecular Therapy, Vaccinology • By Sales channel (Revenue, USD Million; 2016-2026), Channel sales, Direct Sales • By End user: (Revenue, USD Million; 2016-2026), Pharmaceutical and Biopharmaceutical , Companies, Research Institutes www.reportsanddata.com

  4. Regional Viral Vector and Plasmid DNA Manufacturing Market (Regional Output, Demand & Forecast by Countries):- • North America (United States, Canada, Mexico) • South America (Brazil, Argentina, Ecuador, Chile) • Asia Pacific (China, Japan, India, Korea) • Europe (Germany, UK, France, Italy) • Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More. www.reportsanddata.com

  5. Major highlights of the report: • An all-inclusive evaluation of the parent market • The evolution of significant market aspects • Industry-wide investigation of market segments • Assessment of the market value and volume in the past, present and forecast years • Market share evaluation • Study of niche industrial sectors • Tactical approaches of the market leaders • Lucrative strategies to help companies strengthen their position in the market www.reportsanddata.com

  6. About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related